MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Healthcare Medical Devices

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc > https://www.bnnbloomberg.ca/u-s-to-pay-1-2-billion-for-187-m

<< Previous

Bullboard Posts

Next >>

Comment by HouseSpeaker007on Sep 22, 2021 6:40am

135 Views

Post# 33897136

RE:https://www.bnnbloomberg.ca/u-s-to-pay-1-2-billion-for-187-m

this is all very good, Abbot is an American company and any funds funneled out of the American government for procurement will be awarded to American producers on a first basis priority.

<< Previous

Bullboard Posts

Next >>

Calibre discovers significant gold in Newfoundland